Stay updated on Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:52:33.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to include new collaborators, a revised version number, and a specific registry identifier for a clinical trial. However, significant core content regarding the study's objectives and treatment details has been removed.
    Difference
    54%
    Check dated 2025-04-16T01:47:25.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 11, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.2%
    Check dated 2025-04-08T20:32:04.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 11, 2025, and version 2.14.2.
    Difference
    0.1%
    Check dated 2025-04-01T15:31:47.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page has updated the study dates and removed outdated information regarding a pilot study involving Pembrolizumab and liver-directed therapies for neuroendocrine tumors.
    Difference
    0.8%
    Check dated 2025-03-18T04:55:24.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T19:06:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.